Vimarsana
Biggest News Aggregation in the World

Page 16 - Jeff Hauser News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeff Hauser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeff Hauser Today - Breaking & Trending Today

Playbook PM: Senate Dems ramp up calls for Menendez's resignation - Vimarsana News

Playbook PM: Senate Dems ramp up calls for Menendez's resignation

And the latest on Congress' spending fight.

Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm - Vimarsana News

Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm

Washington’s revolving door kept spinning this week as the Drug Enforcement Administration’s recently departed second-in-command returned for another stint with a high-powered consulting firm where he previously advised OxyContin maker

Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm | U.S. - Vimarsana News

Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm | U.S.

Louis Milione had retired from the DEA this summer for a second time amid reporting by The Associated Press on potential conflicts caused by his prior consulting for the pharmaceutical industry

Source: elpais.com
Revolving door redux | News, Sports, Jobs - The Mining Journal - Vimarsana News

Revolving door redux | News, Sports, Jobs - The Mining Journal

WASHINGTON (AP) — Washington’s revolving door kept spinning this week as the Drug Enforcement Administration’s recently departed second-in-command returne

Former DEA official back to Big Pharma as consultant - Vimarsana News

Former DEA official back to Big Pharma as consultant

Washington’s revolving door kept spinning this week as the Drug Enforcement Administration’s recently departed second-in-command returned for another stint with a high-powered consulting firm where he previously advised OxyContin maker